Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Die Folgen des Klimwandels haben einen direkten Einfluss auf die Primärversorgung in Deutschland: Hitzeschutz insbesondere bei älteren Patienten, die Zunahme von Infektionen und die Verlängerung der Allergiesesaison spielen medizinisch eine bedeutsame Rolle. Aber auch in der Prävention und der Aufklärung der Patienten kommt den Hausärztinnen und -ärzten eine besondere Rolle zu. Direkt aus der Praxis berichtet im Live-Webinar am 13. Mai von 18 bis 19 Uhr unser Experte Dr. med. Robin Maitra.
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 8/2016

01.08.2016 | Immunology and Transplantation (L Piemonti and V Sordi, Section Editors)

Follicular Helper T Cells in Autoimmunity

verfasst von: Martin G. Scherm, Verena B. Ott, Carolin Daniel

Erschienen in: Current Diabetes Reports | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

The development of multiple disease-relevant autoantibodies is a hallmark of autoimmune diseases. In autoimmune type 1 diabetes (T1D), a variable time frame of autoimmunity precedes the clinically overt disease. The relevance of T follicular helper (TFH) cells for the immune system is increasingly recognized. Their pivotal contribution to antibody production by providing help to germinal center (GC) B cells facilitates the development of a long-lived humoral immunity. Their complex differentiation process, involving various stages and factors like B cell lymphoma 6 (Bcl6), is strictly controlled, as anomalous regulation of TFH cells is connected with immunopathologies. While the adverse effects of a TFH cell-related insufficient humoral immunity are obvious, the role of increased TFH frequencies in autoimmune diseases like T1D is currently highlighted. High levels of autoantigen trigger an excessive induction of TFH cells, consequently resulting in the production of autoantibodies. Therefore, TFH cells might provide promising approaches for novel therapeutic strategies.
Literatur
1.
Ehrlich P, Morgenroth J. Ueber Hämolysine : fünfte Mittheilung. Berliner klinische Wochenschrift. 1901;38:251–7.
2.
Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464(7293):1293–300.CrossRefPubMed
3.
4.
5.
6.
7.
Goris A, Liston A. The immunogenetic architecture of autoimmune disease. Cold Spring Harb Perspect Biol. 2012. 4(3).
8.
Bennett CL et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20–1.CrossRefPubMed
9.
Finnish-German AC. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17(4):399–403.CrossRef
10.
11.
Vandenbroeck K. Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Interferon Cytokine Res. 2012;32(4):139–51.CrossRefPubMedPubMedCentral
12.
Elliott M et al. Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann N Y Acad Sci. 2009;1182:97–110.CrossRefPubMed
13.
Papp KA et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366(13):1181–9.CrossRefPubMed
14.
15.
Root-Bernstein R, Fairweather D. Complexities in the relationship between infection and autoimmunity. Curr Allerg Asthma Rep. 2014;14(1):407.CrossRef
16.
17.
Mikuls TR et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthrit Rheumatol. 2014;66(5):1090–100.CrossRef
18.
Ochoa-Reparaz J et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol. 2010;185(7):4101–8.CrossRefPubMed
19.
20.
21.
Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1(1):69–75.CrossRefPubMed
22.
Abdollahi-Roodsaz S et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest. 2008;118(1):205–16.CrossRefPubMed
23.
24.
Kuhn A, Wenzel J, Weyd H. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol. 2014;47(2):148–62.CrossRefPubMed
25.
26.
Bluestone JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol. 2008;28(6):677–84.CrossRefPubMed
27.
Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10(12):849–59.CrossRefPubMedPubMedCentral
28.
Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51(12):3353–61.CrossRefPubMed
29.
30.
Insel RA et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964–74.CrossRefPubMed
31.
McLaughlin KA, Richardson CC, Ravishankar A, Brigatti C, Liberati D, Lampasona V, et al. Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes. 2016.
32.
33.
Krischer JP, Type 1 Diabetes TrialNet Study Group . The use of intermediate endpoints in the design of type 1 diabetes prevention trials. Diabetologia. 2013;56(9):1919–24.CrossRefPubMedPubMedCentral
34.
Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 1995;268(5214):1185–8.CrossRefPubMed
35.
Anderson JT et al. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity. 1993;15(2):113–22.CrossRefPubMed
36.
Ferraro A et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011;60(11):2903–13.CrossRefPubMedPubMedCentral
37.••
Baumjohann D et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38(3):596–605. This is an important paper showing that the amount of antigen determines the quantity and duration of the TFH cell response in a murine model.CrossRefPubMed
38.••
Kenefeck R et al. Follicular helper T cell signature in type 1 diabetes. J Clin Invest. 2015;125(1):292–303. This paper highlights a clear association between TFH cells and T1D in a murine model and in human peripheral blood.CrossRefPubMed
39.••
Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41(4):529–42. This is a useful, broad review of TFH cell differentiation, regulation, function, and their role in disease.CrossRefPubMedPubMedCentral
40.
Ansel KM et al. In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med. 1999;190(8):1123–34.CrossRefPubMedPubMedCentral
41.
Schaerli P et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med. 2000;192(11):1553–62.CrossRefPubMedPubMedCentral
42.
Haynes NM et al. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179(8):5099–108.CrossRefPubMed
43.
Breitfeld D et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192(11):1545–52.CrossRefPubMedPubMedCentral
44.
Chtanova T et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173(1):68–78.CrossRefPubMed
45.
Morita R et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108–21.CrossRefPubMedPubMedCentral
46.
47.
48.
Goenka R et al. Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation. J Immunol. 2011;187(3):1091–5.CrossRefPubMedPubMedCentral
49.
Odegard JM et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med. 2008;205(12):2873–86.CrossRefPubMedPubMedCentral
50.
51.
Choi YS et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity. 2011;34(6):932–46.CrossRefPubMedPubMedCentral
52.
53.
Johnston RJ et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009;325(5943):1006–10.CrossRefPubMedPubMedCentral
54.•
Stone EL et al. ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation. Immunity. 2015;42(2):239–51. This paper indicates that ICOS transiently inactivates Foxo1 to promote Bcl6 expression and generation of TFH cells.CrossRefPubMedPubMedCentral
55.
56.•
Wang H et al. The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells. Nat Immunol. 2014;15(7):667–75. This paper demonstrates that CD4+ T cells deficient in Foxp1 might enhance TFH cell differentiation and GC and antibody responses.CrossRefPubMedPubMedCentral
57.
Vogelzang A et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity. 2008;29(1):127–37.CrossRefPubMed
58.
59.
Akiba H et al. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J Immunol. 2005;175(4):2340–8.CrossRefPubMed
60.
61.
Weinstein JS et al. B cells in T follicular helper cell development and function: separable roles in delivery of ICOS ligand and antigen. J Immunol. 2014;192(7):3166–79.CrossRefPubMedPubMedCentral
62.
Hu J, Havenar-Daughton C, Crotty S. Modulation of SAP dependent T:B cell interactions as a strategy to improve vaccination. Curr Opin Virol. 2013;3(3):363–70.CrossRefPubMedPubMedCentral
63.
64.
65.
Kitano M et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity. 2011;34(6):961–72.CrossRefPubMed
66.•
Wang CJ et al. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement. Proc Natl Acad Sci U S A. 2015;112(2):524–9. Useful paper that shows that CTLA-4 deficiency causes excessive CD28 stimulation and thereby regulation of TFH cell differentiation and GC formation.CrossRefPubMed
67.
Kuipers H et al. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo. J Immunol. 2010;185(1):400–9.CrossRefPubMed
68.
Kuipers H, Schnorfeil FM, Brocker T. Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell development. Mol Immunol. 2010;48(1–3):333–40.CrossRefPubMed
69.
Turner ML, Schnorfeil FM, Brocker T. MicroRNAs regulate dendritic cell differentiation and function. J Immunol. 2011;187(8):3911–7.CrossRefPubMed
70.
Baumjohann D et al. The microRNA cluster miR-17 approximately 92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat Immunol. 2013;14(8):840–8.CrossRefPubMedPubMedCentral
71.
72.
73.
Hams E et al. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells. J Immunol. 2011;186(10):5648–55.CrossRefPubMed
74.
Good-Jacobson KL et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010;11(6):535–42.CrossRefPubMedPubMedCentral
75.
Bentebibel SE. Induction of ICOS + CXCR3 + CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med. 2013;5(176):176ra32.CrossRefPubMedPubMedCentral
76.
77.
Harker JA et al. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science. 2011;334(6057):825–9.CrossRefPubMedPubMedCentral
78.
79.
Rivino L et al. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J Virol. 2013;87(5):2693–706.CrossRefPubMedPubMedCentral
80.
Kawamoto S, Maruya M, Kato LM, Suda W, Atarashi K, Doi Y, et al. Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity. 2014;41:152–65.CrossRefPubMed
81.
Al-Herz W et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2014;5:162.PubMedPubMedCentral
82.
Cubas RA et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med. 2013;19(4):494–9.CrossRefPubMed
83.
Ballesteros-Tato A et al. T follicular helper cell plasticity shapes pathogenic T helper 2 cell-mediated immunity to inhaled house dust mite. Immunity. 2016;44(2):259–73.CrossRefPubMed
84.
Bubier JA et al. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc Natl Acad Sci U S A. 2009;106(5):1518–23.CrossRefPubMedPubMedCentral
85.
Szabo K et al. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren’s syndrome and systemic lupus erythematosus. Clin Exp Immunol. 2016;183(1):76–89.CrossRefPubMed
86.
87.
Ferreira RC et al. IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia. 2015;58(4):781–90.CrossRefPubMedPubMedCentral
88.
Xu H et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 2013;496(7446):523–7.CrossRefPubMed
89.
Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther. 2005;12(6):580–91.CrossRefPubMed
90.
Butler NS et al. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol. 2012;13(2):188–95.CrossRef
91.
Obeng-Adjei N et al. Circulating Th1-Cell-type Tfh cells that exhibit impaired B cell help are preferentially activated during acute malaria in children. Cell Rep. 2015;13(2):425–39.CrossRefPubMedPubMedCentral
92.
Wei M et al. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat Immunol. 2011;12(3):264–70.CrossRefPubMed
Metadaten
Titel
Follicular Helper T Cells in Autoimmunity
verfasst von
Martin G. Scherm
Verena B. Ott
Carolin Daniel
Publikationsdatum
01.08.2016
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 8/2016
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-016-0770-2

Weitere Artikel der Ausgabe 8/2016

Current Diabetes Reports 8/2016 Zur Ausgabe

Economics and Policy in Diabetes (ES Huang and AA Baig, Section Editors)

International Models of Care that Address the Growing Diabetes Prevalence in Developing Countries

Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Fear of Hypoglycemia in Children and Adolescents and Their Parents with Type 1 Diabetes

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?

Psychosocial Aspects (S Jaser and KK Hood, Section Editors)

Camp for Youth With Type 1 Diabetes

Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)

Co-Managing Patients with Type 1 Diabetes and Cancer

Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor)

Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

10.05.2024 Periphere arterielle Verschlusskrankheit Nachrichten

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise